[{"Assets_0_Q2_USD":"15582200000.0","CIK":"875320","CommonStockSharesIssued_0_Q2_shares":"256026201.0","CommonStockSharesOutstanding_0_Q2_shares":"256026201.0","Country":"United States","EarningsPerShareBasic_1_Q2_USD":"3.17","EarningsPerShareBasic_2_Q2_USD":"6.15","EarningsPerShareDiluted_1_Q2_USD":"3.13","EarningsPerShareDiluted_2_Q2_USD":"6.09","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","Market Cap":"72193451271.0","NetCashProvidedByUsedInOperatingActivitiesConverted_2_Q2_USD":"2096000000.0","NetIncomeLoss_1_Q2_USD":"810500000.0","NetIncomeLoss_2_Q2_USD":"1572600000.0","OfficialName":"Vertex Pharmaceuticals Incorporated Common Stock","RevenuesConverted_1_Q2_USD":"2196200000.0","RevenuesConverted_2_Q2_USD":"4293700000.0","SP500":"SP500","Sector":"Health Care","StockholdersEquity_0_Q2_USD":"11933500000.0","Ticker":"VRTX","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":"258700000.0","WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":"258300000.0","WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":"255900000.0","WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":"255500000.0","filed":"20220805","footnote":null,"form":"10-Q","fp":"Q2","fy":"2022.0","name":"VERTEX PHARMACEUTICALS INC \/ MA","period":"20220630","qtrs":"0","uom":"USD"}]